3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
7
Unknown
2
Recruiting
2
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Neoplasm Metastasis
10
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
9
Lung Neoplasms
5
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Neoplasms
4
Leukemia, Myeloid, Acute
4
Colorectal Neoplasms
4
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Melanoma
3
Leukemia
3
Glioblastoma
3
Cholangiocarcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Recurrence
2
Gliosarcoma
2
Glioma
2
Congenital Abnormalities
2
Colonic Neoplasms
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stomatitis
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleural Effusion, Malignant
1
Pain
1
Interventions
Cisplatin
11
Cetuximab
10
Radiotherapy
7
Fluorouracil
6
Docetaxel
5
pembrolizumab
4
Carboplatin
4
figitumumab
3
Radiation
3
Paclitaxel
3
Erlotinib Hydrochloride
3
Bleomycin
3
130-nm albumin-bound paclitaxel
3
talimogene laherparepvec
2
avelumab
2
Surgical Procedures, Operative
2
Oxaliplatin
2
Lapatinib
2
Capecitabine
2
zalutumumab
1
yeast-CEA vaccine
1
temsirolimus
1
temoporfin
1
smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic
1
selinexor
1
remetinostat
1
ponatinib
1
patritumab
1
nilotinib
1
necitumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma, Squamous Cell
×
Drug Therapy
×
Clear all
NCT02819752
2026-04-09
PEACH
Royal Marsden NHS Foundation Trust
Phase 1
Terminated
3 enrolled
12 charts